Fortrea Holdings Inc. Share Price & Technical Analysis
FTRE · $13.24 (+0.76%)
Healthcare / Biotechnology
$13.24
+0.76%
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling…
Price chart
Seasonality
May has 1 positive and 2 negative years (last 4 years shown)
13% return in May, -31% avg return in past 3 year May month.
-12% return in 2026, 14% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -3% | -36% | -9% | 22% | 13% | – | – | – | – | – | – | – | -12% |
| 25 | -11% | -15% | -21% | -17% | -31% | 14% | 16% | 65% | -12% | 24% | 21% | 38% | 70% |
| 24 | -10% | 21% | 8% | -10% | -31% | -8% | 17% | -16% | -12% | -15% | 24% | -11% | -45% |
| 23 | – | – | – | – | – | 13% | -5% | -13% | 3% | -1% | 4% | 16% | 16% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Strong · Uptrend
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and biometrics; and clinical development, including phase I through IV clinical and real-world evidence studies, regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, comprehensive site and medical monitoring, data management and biostatistics, pharmacovigilance, medical writing, and mobile clinical services. The company also provides consulting services comprising product development and regulatory, market access and health economics, and outcomes research, as well as RWE services. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$1.36B
P/E ratio
—
52W high
$18.67
52W low
$3.97
Volume
4,57,297
Beta
1.91
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Fortrea Holdings Inc. share price today?
- Fortrea Holdings Inc. (FTRE) last traded around $13.24 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does FTRE have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for FTRE. Download the app for real-time alerts.
- How can I analyze Fortrea Holdings Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.